318 related articles for article (PubMed ID: 17890894)
21. Survey of genetic alterations in gastrinomas.
Yu F; Jensen RT; Lubensky IA; Mahlamaki EH; Zheng YL; Herr AM; Ferrin LJ
Cancer Res; 2000 Oct; 60(19):5536-42. PubMed ID: 11034099
[TBL] [Abstract][Full Text] [Related]
22. Collision of extensive exocrine and neuroendocrine neoplasms in multiple endocrine neoplasia type 1 revealed by cytogenetic analysis of loss of heterozygosity: a case report.
Moriyoshi K; Minamiguchi S; Miyagawa-Hayashino A; Fujimoto M; Kawaguchi M; Haga H
Pathol Int; 2013 Sep; 63(9):469-75. PubMed ID: 24200159
[TBL] [Abstract][Full Text] [Related]
23. Gastrinoma--morphological aspects.
Klöppel G; Anlauf M
Wien Klin Wochenschr; 2007; 119(19-20):579-84. PubMed ID: 17985091
[TBL] [Abstract][Full Text] [Related]
24. Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors.
Klöppel G; Anlauf M; Perren A
Endocr Pathol; 2007; 18(3):150-5. PubMed ID: 18058264
[TBL] [Abstract][Full Text] [Related]
25. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
26. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?
Bartsch DK; Langer P; Wild A; Schilling T; Celik I; Rothmund M; Nies C
Surgery; 2000 Dec; 128(6):958-66. PubMed ID: 11114630
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
[TBL] [Abstract][Full Text] [Related]
28. Multiple neuroendocrine tumors in the stomach, duodenum and pancreas of a MEN1 patient.
Wang S; Zhang W; Xu M; Xia M
Rev Esp Enferm Dig; 2024 Jun; 116(6):339-341. PubMed ID: 37350653
[TBL] [Abstract][Full Text] [Related]
29. [About a case of multiple endocrine neoplasia type 1. Review of some clinical manifestations and treatment controversies].
Familiar C; Antón T; Moraga I; Ramos A; Marco A
Endocrinol Nutr; 2011 Feb; 58(2):84-9. PubMed ID: 21339088
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia type 1-associated cystic pancreatic endocrine neoplasia and multifocal cholesterol granulomas.
Kimura N; Komuro K; Uchino S; Yagihashi S; Ishidate T; Ishizaka M
Pathol Int; 2010 Apr; 60(4):321-5. PubMed ID: 20403035
[TBL] [Abstract][Full Text] [Related]
31. Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1.
Hackeng WM; van Beek DJ; Kok ASM; van Emst M; Morsink FHM; van Treijen MJC; Borel Rinkes IHM; Dreijerink KMA; Offerhaus GJA; Valk GD; Vriens MR; Brosens LAA
Am J Surg Pathol; 2022 Feb; 46(2):159-168. PubMed ID: 34560682
[TBL] [Abstract][Full Text] [Related]
32. Lymph node gastrinoma in multiple endocrine neoplasia type 1 - a diagnostic challenge.
Müssig K; Wehrmann M; Horger M; Bares R; Häring HU; Gallwitz B; Petersenn S
Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):554-7. PubMed ID: 18523912
[TBL] [Abstract][Full Text] [Related]
33. Hyperplasia to neoplasia sequence of duodenal and pancreatic neuroendocrine diseases and pseudohyperplasia of the PP-cells in the pancreas.
Klöppel G; Anlauf M; Perren A; Sipos B
Endocr Pathol; 2014 Jun; 25(2):181-5. PubMed ID: 24718881
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
35. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
36. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
[TBL] [Abstract][Full Text] [Related]
37. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
[TBL] [Abstract][Full Text] [Related]
38. [Hereditary tumours of the endocrine pancreas].
Igaz P; Igaz I; Rácz K; Tulassay Z
Orv Hetil; 2006 Feb; 147(5):195-200. PubMed ID: 16509219
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1.
Vidal A; Iglesias MJ; Fernández B; Fonseca E; Cordido F
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):835-8. PubMed ID: 18435740
[TBL] [Abstract][Full Text] [Related]
40. Non-islet origin of pancreatic islet cell tumors.
Vortmeyer AO; Huang S; Lubensky I; Zhuang Z
J Clin Endocrinol Metab; 2004 Apr; 89(4):1934-8. PubMed ID: 15070966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
